Free Trial

RE/MAX (RMAX) to Release Quarterly Earnings on Tuesday

RE/MAX logo with Finance background

RE/MAX (NYSE:RMAX - Get Free Report) is expected to be posting its Q2 2025 quarterly earnings results after the market closes on Tuesday, July 29th. Analysts expect RE/MAX to post earnings of $0.35 per share and revenue of $74.24 million for the quarter.

RE/MAX Trading Down 4.1%

RMAX traded down $0.35 during trading on Thursday, reaching $8.31. The stock had a trading volume of 176,365 shares, compared to its average volume of 163,428. The stock's 50 day moving average is $8.00 and its two-hundred day moving average is $8.56. The company has a market capitalization of $165.58 million, a price-to-earnings ratio of 19.32 and a beta of 1.17. RE/MAX has a one year low of $6.90 and a one year high of $14.31.

Insider Transactions at RE/MAX

In other RE/MAX news, EVP Abigail C. Lee sold 10,000 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $7.78, for a total value of $77,800.00. Following the transaction, the executive vice president directly owned 151,874 shares of the company's stock, valued at approximately $1,181,579.72. This trade represents a 6.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 6.80% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Empowered Funds LLC boosted its position in RE/MAX by 7.1% in the first quarter. Empowered Funds LLC now owns 124,913 shares of the financial services provider's stock worth $1,046,000 after purchasing an additional 8,318 shares during the last quarter. Jane Street Group LLC boosted its position in RE/MAX by 388.7% in the first quarter. Jane Street Group LLC now owns 57,213 shares of the financial services provider's stock worth $479,000 after purchasing an additional 45,506 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in RE/MAX in the first quarter worth about $129,000. Finally, Strs Ohio purchased a new position in RE/MAX in the first quarter worth about $30,000. 93.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on RMAX shares. Wall Street Zen cut RE/MAX from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 12th. Keefe, Bruyette & Woods dropped their price objective on RE/MAX from $10.00 to $9.00 and set a "market perform" rating on the stock in a research report on Monday, April 28th.

Get Our Latest Report on RE/MAX

About RE/MAX

(Get Free Report)

RE/MAX Holdings, Inc operates as a franchisor of real estate brokerage services in the United States, Canada, and internationally. It operates through Real Estate, Mortgage, and Marketing Funds segments. The company offers real estate brokerage franchising services under the RE/MAX brand; mortgage brokerage services to real estate brokers, real estate professionals, mortgage professionals, and other investors under the Motto Mortgage brand; and mortgage loan processing software and services under the wemlo brand.

Featured Articles

Earnings History for RE/MAX (NYSE:RMAX)

Should You Invest $1,000 in RE/MAX Right Now?

Before you consider RE/MAX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RE/MAX wasn't on the list.

While RE/MAX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines